|Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Nifedipine.
|WikiProject Pharmacology||(Rated B-class, Mid-importance)|
|WikiProject Women's Health||(Rated B-class)|
|WikiProject Medicine||(Rated B-class, Mid-importance)|
This was added:
Male Contraceptive Effects
- Nifedipine and other calcium-channel blockers may interfere with the normal development of sperm, potentially reducing the fertility of men who take it. It has been studied by at least one researcher as a potential reversible male contraceptive,  however, it is not being actively pursued as a contraceptive by any major pharmaceutical companies, possibly because of perceptions that publicizing its contraceptive effects would negatively impact sales as a blood-pressure medication, or because an expired patent and the availability of inexpensive generics makes research into new uses an unappealing financial prospect.
- At least one case of possible Nifedipine-induced infertility has been reported in the literature. .
- Couples who are having difficulty conceiving should consult their doctor if the man is taking nifedipine.
- The apparent contraceptive mechanism is an inhibition of the normal mannose lectin coating of the spermatozoa's outer membrane; this coating is necessary for correct binding with the egg. This may be caused when a greater-than-normal amount of cholesterol is integrated into the membrane, stiffening the membrane and preventing normal outward migration of mannose from the interior.
This is completely disproportionate to the rest of the article. One researcher pushing it and one case report on infertility make this too obscure for a general encyclopedia. JFW | T@lk 22:54, 10 October 2006 (UTC)
- I don't think it was right to remove this. Safety warnings are of the utmost importance. --IO Device (talk) 22:10, 22 March 2009 (UTC)
This medication is deadly if taken in overdose. It should be kept out of the reach of children and anyone suspested of being depressed or suicidal. —Preceding unsigned comment added by 126.96.36.199 (talk) 16:13, 10 January 2010 (UTC)
Could someone mention Procardia XL dosage form release mechanism. Specifically that it is a plastic shell with a small opening that lets the drug out slowly. This is important since the nifedipine is released later and over a different kinetic time period. Also the shell can form a pseudobezoar within the patient. --188.8.131.52 (talk) 16:15, 10 April 2011 (UTC) Procardia XL is an osmotic push-pull system. See Wikipedia "Osmotic controlled-release oral delivery system" or abbreviated OROS for an explanation. Because the shell of the system cannot be digested and is emptying within about 24h, it can in rare cases be collected in the stomach. The stomach has an sphincter muscle that is controlling the food and liquid transport to the small intestine. Larger bodies like the empty OROS shell may not pass this sphincter. This empty shell is called a bezoar. firstname.lastname@example.org
Is this drug a cyp3a4 inhibitor? I know it is a substrate, but data on whether or not is inhibits said enzyme is contradictory at best. I know it could THEROTICALLY produce inhibition via competing with other drugs for the limited enzyme, but does this translate to having any useful inhibtion activity, and if so would it be worth taking as a inhibitor??? — Preceding unsigned comment added by 184.108.40.206 (talk) 23:18, 14 September 2011 (UTC)
Mechanism of action
The following was added by Herizora:
|“||As a calcium channel blocker, nifedipine is expected to inhibit the currents of L-type Cav1.3 channels in the zona glomerulosa of the adrenal, reducing aldosterone production and corroborating to lower blood pressure.||”|
It contains only primary sources, and the titles of the journal articles don't give the impression that they are primarily about the mechanism of nifedipine. I would recommend WP:MEDRS-compatible secondary sources in the first instance. JFW | T@lk 22:11, 26 October 2014 (UTC)
Seriously? You base your judgement on the TITLES of research articles?
- The TITLES of the journal articles? Seriously? This Jfdwolff guy didn't even read the actual research. Anyone can write a book (your secondary resources) and write whatever they like in it. Now talk about peer reviewed scientific articles. Take the time to read these references, if reading will actually make you understand what is written in them. If you can actually understand something that is not the instructions manual of Wikipedia, which I do believe you can't. Herizora (talk) 22:45, 26 October 2014 (UTC)
- Herizora Please don't attack the messenger. Have you read WP:MEDRS? It is quite specific about the importance of using secondary sources. Many primary research studies cannot be replicated (even those published in Nature cannot always be replicated, see doi:10.1038/496398a). JFW | T@lk 08:46, 28 October 2014 (UTC)
- Herizora I agree in principle that it is much better to review the entire article. However, I don't always have access to the full text and it is generally not difficult to distinguish on the basis of more limited information alone.
- I see that most of the additions are based on your PhD work. I really do hope that I can convince you to stick around and contribute further within the constraints of our policies. JFW | T@lk 11:51, 28 October 2014 (UTC)
- Jfdwolff Although I did not take the trouble of adding the reference, the suggestions that nifedipine and other calcium channel blockers can reduce aldosterone levels in human subjects has been published by several groups as far as 1998 (16 years). It is possible to google it up, but then the title of the research papers may not give you the right clue about the contents. Herizora (talk) 13:14, 28 October 2014 (UTC)
Hello fellow Wikipedians,
I have just modified one external link on Nifedipine. Please take a moment to review my edit. If you have any questions, or need the bot to ignore the links, or the page altogether, please visit this simple FaQ for additional information. I made the following changes:
- Added archive https://web.archive.org/web/20150910023142/http://www.dr-bob.org/tips/split/Nifed-MAOI-hypertension.html to http://www.dr-bob.org/tips/split/Nifed-MAOI-hypertension.html
When you have finished reviewing my changes, you may follow the instructions on the template below to fix any issues with the URLs.
You may set the
|checked=, on this template, to true or failed to let other editors know you reviewed the change. If you find any errors, please use the tools below to fix them or call an editor by setting
|needhelp= to your help request.
- If you have discovered URLs which were erroneously considered dead by the bot, you can report them with this tool.
- If you found an error with any archives or the URLs themselves, you can fix them with this tool.
If you are unable to use these tools, you may set
|needhelp=<your help request> on this template to request help from an experienced user. Please include details about your problem, to help other editors.
- Goodwin, LO, NB Leeds, I Hurley, FS Mandel, RG Pergolissi and S Benoff (1997) “Isolation and characterization of the primary structure of testis-specific L-type calcium channel: implications for contraception.” Molecular Human Reproduction 3(3): 255-68.
- Benoff, S (1998) “Voltage dependent calcium channels in mammalian spermatozoa.” Frontiers in Bioscience 3: D1220-40.
- Azizan EA, Poulsen H, Tuluc P, Zhou J, Clausen MV, Lieb A, Maniero C, Garg S, Bochukova EG, Zhao W, Shaikh LH, Brighton CA, Teo AE, Davenport AP, Dekkers T, Tops B, Küsters B, Ceral J, Yeo GS, Neogi SG, McFarlane I, Rosenfeld N, Marass F, Hadfield J, Margas W, Chaggar K, Solar M, Deinum J, Dolphin AC, Farooqi IS, Striessnig J, Nissen P, Brown MJ. (2013). "Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension". Nature Genetics. 45 (9): 1055–1060. doi:10.1038/ng.2716. PMID 23913004.
- Felizola SJA, Maekawa T, Nakamura Y, Satoh F, Ono Y, Kikuchi K, Aritomi S, Ikeda K, Yoshimura M, Tojo K, Sasano H. (2014). "Voltage-gated calcium channels in the human adrenal and primary aldosteronism". J Steroid Biochem Mol Biol. 144 (part B): 410–416. doi:10.1016/j.jsbmb.2014.08.012. PMID 25151951.